[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,448,728
  • Shares Outstanding, K 2,042,071
  • Annual Sales, $ 48,194 M
  • Annual Income, $ 7,054 M
  • EBIT $ 12,521 M
  • EBITDA $ 16,532 M
  • 60-Month Beta 0.23
  • Price/Sales 2.67
  • Price/Cash Flow 7.76
  • Price/Book 6.41

Options Overview Details

View History
  • Implied Volatility 29.86% (-0.18%)
  • Historical Volatility 30.11%
  • IV Percentile 54%
  • IV Rank 45.88%
  • IV High 40.88% on 11/19/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 7) 1.87 (2.86%)
  • Put/Call Vol Ratio 1.58
  • Today's Volume 41,460
  • Volume Avg (30-Day) 29,303
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 726,278
  • Open Int (30-Day) 620,387
  • Expected Range 63.44 to 67.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.63
  • Number of Estimates 9
  • High Estimate $1.73
  • Low Estimate $1.56
  • Prior Year $1.63
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.30 +16.00%
on 07/01/26
65.66 -0.53%
on 07/31/26
+7.69 (+13.35%)
since 06/30/26
3-Month
53.44 +22.21%
on 06/18/26
65.66 -0.53%
on 07/31/26
+4.72 (+7.79%)
since 04/30/26
52-Week
42.52 +53.60%
on 10/29/25
65.66 -0.53%
on 07/31/26
+19.33 (+42.04%)
since 07/30/25

Most Recent Stories

More News
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

BMY : 65.31 (+0.69%)
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

BMY : 65.31 (+0.69%)
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

Bristol Myers Squibb (NYSE: BMY) today reported second quarter 2026 financial results. Visit the company’s Investor Relations website at http://investor.bms.com ...

BMY : 65.31 (+0.69%)
Bristol-Myers Squibb: Wall Street's Bearish Revisions May Have Overcorrected This Time

Barchart Research What to Expect from BMY Earnings BMY Generated July 29, 2026 Current Price $63.10 EPS Estimate $$1.59 Consensus Rating Moderate Buy Average Move 5.36% Bristol-Myers Squibb: Wall Street's...

BMY : 65.31 (+0.69%)
Bristol-Myers Squibb Stock: Analyst Estimates & Ratings

Bristol-Myers Squibb has rallied the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

XLV : 162.55 (-0.59%)
$SPX : 7,489.72 (+0.70%)
BMY : 65.31 (+0.69%)
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

BMY : 65.31 (+0.69%)
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now

As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal.

MO : 68.33 (+0.57%)
AEP : 127.85 (+0.05%)
BMY : 65.31 (+0.69%)
3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar

CHE : 532.25 (-0.47%)
VTRS : 17.56 (-1.13%)
BMY : 65.31 (+0.69%)
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences BMS will deploy NVIDIA DGX Vera Rubin NVL72 systems...

BMY : 65.31 (+0.69%)
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

Application based on results from SUCCESSOR-2 trial showing oral CELMoD mezigdomide in combination with carfilzomib and dexamethasone significantly improved progression-free survival vs. standard of care...

BMY : 65.31 (+0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 68.26
2nd Resistance Point 66.96
1st Resistance Point 66.14
Last Price 65.31
1st Support Level 64.01
2nd Support Level 62.70
3rd Support Level 61.88

See More

52-Week High 65.66
Last Price 65.31
Fibonacci 61.8% 56.82
Fibonacci 50% 54.09
Fibonacci 38.2% 51.36
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.